Distigmine
Back to searchMolecule Structure
Scientific Name
Distigmine
Description of the Drug
Distigmine is a cholinesterase inhibitor indicated in the treatment of neurogenic bladder dysfunction or myasthenia gravis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB13694
http://www.drugbank.ca/drugs/DB13694
Brand Name(s)
Not Available
Company Owner(s)
Not Available
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Acetylcholinesterase | SINGLE PROTEIN | INHIBITOR | CHEMBL220 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL16674116 |
DrugBank | DB13694 |
PubChem: Thomson Pharma | 16442212 |
PubChem | 3116 |
Nikkaji | J221.234J |
EPA CompTox Dashboard | DTXSID00169484 |
DrugCentral | 927 |
rxnorm | DISTIGMINE |
KEGG Ligand | C16823 |
ChEBI | 80756 |
ZINC | ZINC000003872328 |